Founded
2022
Legal Status
Charitable company
Leader
Dr Kathryn Wagner
Treat NMD exists to accelerate treatments to patients with neuromuscular disease, by engaging withpatient advocacy groups, researchers, clinicians, industry and regulators to advance treatments and sharebest practice.
Year ending 2024
Out of £100 Donation
go into Projects
Total
£2.5M
Total
£2.5M
Income & expenditure over time
Europe
Out of £100 Donation
go into Projects